Edition:
United Kingdom

Insider Trading: Esperion Therapeutics Inc (ESPR.OQ)

ESPR.OQ on NASDAQ Stock Exchange Global Market

51.05USD
22 May 2019
Change (% chg)

-- (--)
Prev Close
$51.05
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
202,342
52-wk High
$60.98
52-wk Low
$35.86

All Insider Trades
Trading Date Name Title Type Shares Traded Price
3 Apr 2019

Bartram (Richard B)

Chief Financial Officer Sell 6,500 $42.71
3 Apr 2019

Bartram (Richard B)

Chief Financial Officer Sell 1,500 $43.62
29 Mar 2019

Mayleben (Timothy M)

Chief Executive Officer Buy 5,000 $40.00
21 Mar 2019

Vitullo (Nicole)

Director Sell 17,790 $0.00
21 Mar 2019

Vitullo (Nicole)

Director Buy 1,356 $0.00
20 Mar 2019

Mayleben (Timothy M)

Chief Executive Officer Buy 5,000 $43.48
19 Mar 2019

Vitullo (Nicole)

Director Sell 1,101,080 $0.00
19 Mar 2019

Vitullo (Nicole)

Director Sell 1,700 $45.25
19 Mar 2019

Vitullo (Nicole)

Director Buy 17,790 $0.00
19 Mar 2019

Vitullo (Nicole)

Director Sell 13,629 $44.66
14 Mar 2019

Biotech Target N V

Beneficial Owner of More than 10% Class Buy 50,000 $49.89
14 Mar 2019

Mayleben (Timothy M)

Chief Executive Officer Buy 5,000 $48.73
12 Mar 2019

Newton (Roger S)

Director Sell 25,000 $50.06
4 Jan 2019

Biotech Target N V

Beneficial Owner of More than 10% Class Buy 80,000 $41.29
24 Dec 2018

Biotech Target N V

Beneficial Owner of More than 10% Class Buy 50,000 $39.91
17 Dec 2018

Biotech Target N V

Beneficial Owner of More than 10% Class Buy 60,000 $47.73
5 Nov 2018

Boxer Capital L L C

Beneficial Owner of More than 10% Class Sell 26,500 $55.21
5 Nov 2018

Boxer Capital L L C

Beneficial Owner of More than 10% Class Sell 5,000 $60.28
5 Nov 2018

Boxer Capital L L C

Beneficial Owner of More than 10% Class Sell 6,500 $56.19
5 Nov 2018

Boxer Capital L L C

Beneficial Owner of More than 10% Class Sell 13,610 $59.48
5 Nov 2018

Boxer Capital L L C

Beneficial Owner of More than 10% Class Sell 6,390 $58.82
5 Nov 2018

Boxer Capital L L C

Beneficial Owner of More than 10% Class Sell 2,000 $57.38
2 Nov 2018

Boxer Capital L L C

Beneficial Owner of More than 10% Class Sell 37,500 $55.25
2 Nov 2018

Boxer Capital L L C

Beneficial Owner of More than 10% Class Sell 2,500 $54.65
2 Nov 2018

Newton (Roger S)

Director Sell 227 $50.76

Institutional Holders

% Shares Owned: 0.00%
# of Holders: 215
Total Shares Held: 29,693,824
3 Mo. Net Change: 756,731
# New Positions: 29
# Closed Positions: 24
# Increased Positions: 96
# Reduced Positions: 79
# Net Buyers: 17

Officers & Directors

Name Age Since Current Position

Timothy Mayleben

57 2012 President, Chief Executive Officer, Director

Richard Bartram

36 2018 Chief Financial Officer and Principal Financial Officer

Narendra Lalwani

65 2018 Executive Vice President - Research & Development

Nicole Vitullo

60 2015 Independent Lead Director

Roger Newton

67 2016 Director

Jay Shepard

2018 Director

Jeffrey Berkowitz

52 2017 Independent Director

Scott Braunstein

55 2016 Independent Director

Dov Goldstein

50 2008 Independent Director

Antonio Gotto

83 2014 Independent Director

Daniel Janney

52 2012 Independent Director

Mark McGovern

65 2014 Independent Director

Gilbert Omenn

77 2014 Independent Director